Notes for: Alpha-Adrenoceptor Blocking DrugsLast edited [08/02/2013 14:58:08]See NICE Hypertension guidance
1. In the treatment of hypertension doxazosin should be considered only as third or fourth line add-on therapy.
2. The modified release formulations of doxazosin are significantly more expensive and offer no significant advantage over standard formulation.
3. If wishing to change patients currently prescribed doxazosin 8 mg XL tablets, it is advisable to change to 4 mg of the standard formulation and titrate up slowly, monitoring the patient.
4. Refer to BNF section 7.4.1 for drugs used in the management of benign prostatic hyperplasia.